Prevalence of human T-lymphotropicvirus types I&II among high risk groups in Sanandaj in 2010.
Abstract Background and Aim: HTLV-I is the etiological cause of adult T-lymphocytic
leukemia (ATL) and a chronic degenerative neurologic disorder, called tropical spastic …
leukemia (ATL) and a chronic degenerative neurologic disorder, called tropical spastic …
[HTML][HTML] Prevalence of human T-lymphotropic virus types I and II in patients with hematological disorders in Isfahan, Iran
Background: Human T-cell lymphotropic virus types Ι and ΙΙ (HTLV-Ι and HTLV-II) are
deltaretroviruses which may cause leukemia, lymphoma and HTLV-associated …
deltaretroviruses which may cause leukemia, lymphoma and HTLV-associated …
Prevalence of human T-lymphotropic virus type 1 among blood donors from Mashhad, Iran
MR Abbaszadegan, M Gholamin… - Journal of clinical …, 2003 - Am Soc Microbiol
The city of Mashhad is the capital of Khorasan, the northeastern province of Iran, which has
been recognized as an area where human T-lymphotropic virus type 1 (HTLV-1) infection is …
been recognized as an area where human T-lymphotropic virus type 1 (HTLV-1) infection is …
A pilot Seroepidemiologic study of HTLV in thalassemia, hemophilia, and hemodialysed patients in Hormozgan
F ABEDI, M YAVARIAN, A Shakibzadeh, B Khalvati… - 2009 - sid.ir
Introduction: Transmission of blood borne infections is common among the
multitransfusionpatients such as THALASSEMIA, HEMOPHILIA and HEMODIALYSIS …
multitransfusionpatients such as THALASSEMIA, HEMOPHILIA and HEMODIALYSIS …
Seroepidemiology of human T-cell lymphotropic virus type 1 infection in Iran: An overview
MMR HEDAYATI - 2013 - sid.ir
Background: Endemicity of HUMAN T-CELL lymphotropic virus type 1 (HTLV-1) infection in
the northeast of Iran as well as noticeable prevalence of the infection in other parts of the …
the northeast of Iran as well as noticeable prevalence of the infection in other parts of the …
Human T-lymphotropic virus type 1 in blood donors from Babol County blood transfusion center: a pilot study from northern Iran
Y Yahyapour, K Aghajanipour, SM Mir… - Jundishapur Journal of …, 2017 - brieflands.com
Background: Human T-lymphotropic virus type 1 (HTLV-1) infection is a major health
problem that effects a variety of endemic regions, including the Northeast of Iran. There is a …
problem that effects a variety of endemic regions, including the Northeast of Iran. There is a …
Survey of the seroprovalence of HTLV I/II in hemodialysis patients and blood donors in Urmia
ZR Khameneh, M Baradaran… - Saudi Journal of Kidney …, 2008 - journals.lww.com
Human T lymphocytotropic virus HTLV is a virus from retroviridae family, and more than 20
million people are infected with this virus worldwide. It can cause leukemia/lymphoma in …
million people are infected with this virus worldwide. It can cause leukemia/lymphoma in …
Evaluating the frequency of human T-lymphotropic virus type 1 infection in Iranian population
S Ferdowsi, M Najafzadeh, MR Ameli… - Iranian Journal of Blood …, 2019 - ijbc.ir
Background: Human T-cell lymphotropic viruses 1 (HTLV1) is endemic in specific regions.
We aimed to determine the prevalence of HTLV I infection among blood donors in southeast …
We aimed to determine the prevalence of HTLV I infection among blood donors in southeast …
Human T-lymphotropic virus type 1 prevalence in northeastern Iran, Sabzevar: an epidemiologic-based study and phylogenetic analysis
MR Azarpazhooh, K Hasanpour… - AIDS research and …, 2012 - liebertpub.com
Human T-lymphotropic virus type 1 (HTLV-I) is an important global health problem in the
world mainly in the endemic areas of HTLV-I infection. It was previously reported that …
world mainly in the endemic areas of HTLV-I infection. It was previously reported that …
Comparison of human T-cell leukemia virus type-1 [HTLV-1] seroprevalence in high risk patients [thalassemia and hemodialysis] and healthy individuals from …
K Ali, N Mohamed Reza, I Reza - 2007 - pesquisa.bvsalud.org
To comapare the seroprevalence of Human Tlymphotropic virus type 1 [HTLV-1] in high risk
group patients [such as those with thalassemia or those who are on hemodialysis] with …
group patients [such as those with thalassemia or those who are on hemodialysis] with …